Riskpilot← Back to searchSign inGet full accessJN Fysioterapi AB
ABActiveOrg 5591212278Eric Perssons Väg 5Physiotherapy activities · NACE 8695Est. 20171 employees
Revenue 2025
SEK 1M
+11% vs 2024
EBITDA margin
8.3%
+526% vs 2024
Equity ratio
26.7%
Financial strength
Net profit 2025
SEK 16K
+117% vs 2024
| Revenue | SEK 1M | +11% |
| EBITDA | SEK 87K | +526% |
| Net profit | SEK 16K | +117% |
| Total assets | SEK 225K | -25% |
| Equity | SEK 60K | +35% |
| Employees | 1 | — |
Legal name
JN Fysioterapi AB
Org number
5591212278
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
8 augusti 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukgymnastiskverksamhet, utbildning och föreläsningar samt därmed förenlig verksamhet.
Address
Eric Perssons Väg 5
Email
j_ohannanilsson@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 171 | 988 | 295 | 948 | 1 049 |
| Staff expenses | — | −600 | −228 | −470 | −698 |
| EBITDA | −10 | 111 | −45 | −20 | 87 |
| Depreciation & amort. | −72 | −72 | −72 | −72 | −72 |
| EBIT | −82 | 39 | −117 | −92 | 15 |
| Net financials | — | 0 | 1 | 1 | 1 |
| Profit before tax | −82 | 39 | −116 | −91 | 16 |
| Tax | −0 | — | — | — | — |
| Net profit | −82 | 39 | −116 | −91 | 16 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 507 | 563 | 394 | 299 | 225 |
| Equity | 212 | 252 | 135 | 45 | 60 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 295 | 312 | 259 | 255 | 165 |
| Total debt | 295 | 312 | 259 | 255 | 165 |
EBITDA margin
8.3%
This company
15.8%
Market median
-47% vs market
20212025
Equity ratio
26.7%
This company
38.2%
Market median
-30% vs market
20212025
Return on equity
25.9%
This company
18.4%
Market median
+41% vs market
20212025
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
20212025
Asset turnover
4.65×
This company
1.12×
Market median
+315% vs market
20212025
Debt / equity
2.75×
This company
0.62×
Market median
-344% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JN Fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johanna Amelie Nilsson | Chief Executive Officer | 0 companies |
| Christer Ronny Nilsson | Deputy Board Member | 0 companies |